SCHEMBL24898091

SCHEMBL24898091

[N-]=[N+]=NC(=O)/C=C/c1ccc(F)cc1C(F)(F)F

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A1 P04798 1/20 0.41
▸ CYP1B1 Q16678 1/20 0.41
▸ MAOB P27338 9/20 0.41
▸ NFKB1 P19838 1/20 0.40
▸ APP P05067 1/20 0.35
▸ P4HB P07237 1/20 0.35
▸ ABCG2 Q9UNQ0 1/20 0.35
▸ ITGB3 P05106 1/20 0.34
▸ ITGAV P06756 1/20 0.34
▸ ITGA2B P08514 1/20 0.34
▸ MAOA P21397 1/20 0.33
▸ BACE1 P56817 1/20 0.33
▸ TDO2 P48775 1/20 0.33
▸ GPR183 P32249 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ HDAC3 O15379 1/20 0.32
▸ HDAC1 Q13547 1/20 0.32
▸ HDAC2 Q92769 1/20 0.32
▸ HDAC6 Q9UBN7 1/20 0.32
▸ MEN1 O00255 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1950607 0.78 TDO2 (0.51) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL1950609 0.78 TDO2 (0.51) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL13729042 0.77 CTSL (0.50) APPKCNH2MEN1MAPTKMT2A
SCHEMBL13729045 0.77 CTSL (0.50) APPKCNH2MEN1MAPTKMT2A
SCHEMBL3214998 0.77 CYP1A1 (0.47) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL5558135 0.77 CYP1A1 (0.47) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL3215005 0.77 CYP1A1 (0.47) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL5558138 0.77 CYP1A1 (0.47) CYP1A1CYP1B1MAOBNFKB1APP
SCHEMBL13730038 0.73 HSD11B1 (0.56) CYP1A1CYP1B1MAOBMAOAMEN1
SCHEMBL13730037 0.73 HSD11B1 (0.56) CYP1A1CYP1B1MAOBMAOAMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023288242-A1 PI3Kα INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-01-19 — — WO disclosed
WO-2023288242-A1 PI3Kα INHIBITORS AND METHODS OF USE THEREOF RELAY THERAPEUTICS, INC. (US) 2023-01-19 — — WO disclosed
Send feedback